Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lu Yanrong is active.

Publication


Featured researches published by Lu Yanrong.


Toxicology and Industrial Health | 2014

Circulating miRNAs might be promising biomarkers to reflect the dynamic pathological changes in smoking-related interstitial fibrosis

Huang Yuchuan; Dai Ya; Zhang Jie; Cheng Jingqiu; Lu Yanrong; Li Dongliang; Wang Changguo; Ma Kuoyan; Liao Guangneng; Xue Fang; Tan Lanlan; Qin Bo

Cigarette smoking is the major risk factor for smoking-related interstitial fibrosis (SRIF). Despite recent advances, the molecular mechanisms involved in the initiation and progression of this disease remain elusive. We found 6 months of chronic mainstream smoking exposure induced SRIF in C57 mice, which was associated with pronounced enhanced oxidative stress, bronchoalveolar inflammation and fibrosis but not apoptosis of alveolar septal cell. We used Affymetrix microRNA (miRNA) arrays to determine the temporal alteration in global gene expression of peripheral blood during the progression of diffuse pulmonary interstitial fibrosis in C57 mice. Microarray analysis revealed the upregulation of 3 miRNAs (miR-92b, miR-700 and miR-668) and the downregulation of 5 miRNAs (let-7e, miR-142-5p, miR-350, miR-19a and miR191*) in the peripheral blood of mice exposed to mainstream smoking for 1, 2, 3 and 6 months. We proposed that circulating miRNAs might be promising biomarkers to reflect the dynamic pathological changes of SRIF related interstitial fibrosis.


Toxicology and Industrial Health | 2011

Circulating biomarkers of hazard effects from cigarette smoking.

Huang Yuchuan; Zhang Jie; Li Dongliang; Dai Ya; Wang Changguo; Ma Kouyan; Cheng Jingqiu; Lu Yanrong; Qin Bo; Xue Fang

Smoking, leading to over 438,000 annual deaths in the US and 92 billion US dollars in lost productivity, is an important risk factor for several diseases. Global smoking statistics for 2002 have shown that 80,000 to 100,000 children worldwide start smoking every day. Human biomonitoring nowadays has provided an efficient and cost-effective means of measuring human exposures and biological effects of smoking. To review the utility of biomarkers in reflecting the hazard from cigarette smoking, we comprehensively searched the Cochrane Library, Medline and EMbase from 1966 to May 2010 with the language limit of English. We found that the currently used biomarkers, such as tobacco-specific metabolites, smoking-induced genotoxic products, may not scientifically reflect the hazard from cigarette smoking. More research is needed to find out more effective biomarkers for estimating hazards from cigarette smoking. This paper is expected to help researchers understand the current utilization of biomarkers related to cigarette smoking and to provide suggestive guides to tobacco companies in producing less-toxic cigarettes, thus to provide a safe way to smoke.Smoking, leading to over 438,000 annual deaths in the US and 92 billion US dollars in lost productivity, is an important risk factor for several diseases. Global smoking statistics for 2002 have shown that 80,000 to 100,000 children worldwide start smoking every day. Human biomonitoring nowadays has provided an efficient and cost-effective means of measuring human exposures and biological effects of smoking. To review the utility of biomarkers in reflecting the hazard from cigarette smoking, we comprehensively searched the Cochrane Library, Medline and EMbase from 1966 to May 2010 with the language limit of English. We found that the currently used biomarkers, such as tobacco-specific metabolites, smoking-induced genotoxic products, may not scientifically reflect the hazard from cigarette smoking. More research is needed to find out more effective biomarkers for estimating hazards from cigarette smoking. This paper is expected to help researchers understand the current utilization of biomarkers related to cigarette smoking and to provide suggestive guides to tobacco companies in producing less-toxic cigarettes, thus to provide a safe way to smoke.


Journal of Huazhong University of Science and Technology-medical Sciences | 2005

In vitro anti-tumor immune response induced by dendritic cells transfected with recombinant adenovirus carrying mutant k-ras genes

Zhao Feng; Zhou Qing-hua; Lu Yanrong; Qin Yang; Zhang Jie; Li Jinsong; Wang Jianjun

SummaryThe specific anti-tumor immune response induced by mouse bone marrow dendritic cells (DCs) transfected with recombinant adenovirus carrying mutant k-ras genes was investigated. DCs were generated from mouse bone marrow in the presence of rmGM-CSF (3.3 ng/mL) and rmIL-4 (1.3 ng/mL) and detected by FACS, and then transfected with the recombinant adenovirus encoding mutant k-ras gene. The efficacy of transfection and T cell stimulating activity of DCs were detected. CTL activity of the mice vaccinated with DCs was observed. The results showed that DCs had dendritic veiled morphology. BmDCs highly expressed B7-1 (80%), B7-2 (77%), MHC II (70%), CD11c (65%), CD40 (70%) and CD54 (96%) with FACS, and no significant difference in the expression was observed before and after the transfection (P>0.05). The DCs transfected by mutant k-ras gene could significantly stimulate lymphocytes proliferation as compared with those transfected by Ad-c or non-modified DCs (P<0.05). DC vaccine transfected by mutant k-ras gene could induce CTL activity against Lewis lung cancer, but not against B16. The specific cytotoxicity against Lewis lung cancer in Ad-k-ras/12-transduced DC group was significantly higher than those in the control, vector and non-transfected DCs groups (P<0.05). It was concluded that special antitumor response could be induced by DCs transfected with recombinant adenovirus carrying mutant k-ras genes.


Archive | 2014

Compound for preventing or treating autoimmune diabetes and preparation method and application thereof

Huang Wen; He Yang; Wu Xiaohua; Lu Yanrong; Cheng Jingqiu


Archive | 2013

Method for preparing rhesus monkey type 2 diabetic model

Chen Younan; Cheng Jingqiu; Lu Yanrong; Liu Jingping; Li Xinli; Yang Guang; Zhang Jie; Liao Guangneng; Li Hongxia; Wang Li; Yuan Yujia; He Sirong; Wang Chengshi


Archive | 2013

Rhesus monkey diabetic nephropathy model preparation method

Lu Yanrong; Cheng Jingqiu; Chen Younan; Liu Jingping; Liu Fang; Yang Lichuan; Wang Li; Li Hongxia; Zhang Jie; Wang Dan; He Sirong; Wang Chengshi; Shi Meimei; Yuan Yujia; Zhao Jiuming


Chinese Medical Sciences Journal | 2016

変形性関節症患者における膝関節の軟骨細胞と滑液におけるmiRNA14の発現【Powered by NICT】

Si Haibo; Zeng Yi; Zhou Zongke; Pei Fuxing; Lu Yanrong; Cheng Jingqiu; Shen Bin


Archive | 2014

METHOD FOR PREPARING RHESUS MACAQUE DIABETES MELLITUS TYPE 2 MODEL

Chen Younan; Cheng Jingqiu; Lu Yanrong; Liu Jingping; Li Xinli; Yang Guang; Zhang Jie; Liao Guangneng; Li Hongxia; Wang Li; Ren Yan; Tian Haoming; Zhong Zhihui


Archive | 2013

Preparation method of rhesus metabolism syndrome model

Chen Younan; Cheng Jingqiu; Lu Yanrong; Liu Jingping; Li Xinli; Yang Guang; Zhang Jie; Liao Guangneng; Li Hongxia; Wang Li; Yuan Yujia; He Sirong; Wang Chengshi


Archive | 2013

Composite manual bile duct and preparation method thereof

Cheng Nansheng; Jiang Xia; Zhang Jie; Xiong Xianze; Lin Yixin; Li Fuyu; Xu Ruihua; Lu Yanrong; Cheng Jingqiu

Collaboration


Dive into the Lu Yanrong's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Li Jinsong

Huazhong University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge